Diagnosis and Treatment of Chronic Insomnia: A Review
Psychiatric ServicesPublished 1 March 2005
Ruth M. Benca
Citations251
SJR quartileQ1
SJR score1.62
SNIP1.35
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Current treatment options do not address the needs of difficult-to-treat patients with chronic insomnia, such as the elderly, and those with comorbid medical and psychiatric conditions.
Abstract
Insomnia is particularly challenging for clinicians because of the lack of guidelines and the small number of studies conducted in patient populations with behavioral and pharmacologic therapies. Current treatment options do not address the needs of difficult-to-treat patients with chronic insomnia, such as the elderly, and those with comorbid medical and psychiatric conditions. More research is necessary to determine the long-term effects of insomnia treatments.
Keywords
PsychologySocial SciencesNeuroscience
JAMAEpidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?
2,453 Citations1989Daniel E. Ford
JAMAEpidemiologic Study of Sleep Disturbances and Psychiatric Disorders
2,251 Citations1989Daniel E. Ford
As part of the National Institute of Mental Health Epidemiologic Catchment Area study, 7954 respondents were questioned at baseline and 1 year later about sleep complaints and psychiatric symptoms using the Diagnostic Interview Schedule.
Biological PsychiatrySleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults
1,828 Citations1996Naomi Breslau, Thomas Roth +2 more
Prior insomnia remained a significant predictor of subsequent major depression when history of other prior depressive symptoms was controlled for, and complaints of 2 weeks or more of insomnia nearly every night might be a useful marker of subsequent onset of major depression.
SLEEPSleep Complaints Among Elderly Persons: An Epidemiologic Study of Three Communities
1,617 Citations1995Daniel J. Foley, Andrew A. Monjan +4 more
In multivariate analyses, sleep complaints were associated with an increasing number of respiratory symptoms, physical disabilities, nonprescription medications, depressive symptoms and poorer self-perceived health.
Archives of General PsychiatrySleep and Psychiatric Disorders
1,449 Citations1992Ruth M. Benca
Findings for patients with affective disorders differed most frequently and significantly from those for normal controls, and patterns of sleep disturbances associated with categories of psychiatric illnesses were observed.
American Journal of PsychiatryNonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy
1,106 Citations1994Charles M. Morin, J P Culbert +1 more
Stimulus control and sleep restriction were the most effective single therapy procedures, whereas sleep hygiene education was not effective when used alone.
JAMABehavioral and Pharmacological Therapies for Late-Life Insomnia
1,088 Citations1999Charles M. Morin, Cheryl Colecchi +3 more
Behavioral and pharmacological approaches are effective for the short-term management of insomnia in late life; sleep improvements are better sustained over time with behavioral treatment.
Archives of General PsychiatryInsomnia and Its Treatment
1,065 Citations1985Glen D. Mellinger
The survey found that insomnia afflicts 35% of all adults during the course of a year; about half of these persons experience the problem as serious; the majority of serious insomniacs were untreated by either prescribed or over-the-counter medications.
SLEEPTreatment of Chronic Insomnia by Restriction of Time in Bed
950 Citations1987Arthur J. Spielman, Paul Saskin +1 more
Although compliance with the restricted schedule is difficult for some patients, sleep restriction therapy is an effective treatment for common forms of chronic insomnia.
SLEEPNonpharmacologic Treatment of Chronic Insomnia
876 Citations1999Charles M. Morin, Peter Hauri +4 more
The findings indicate that nonpharmacological therapies produce reliable and durable changes in several sleep parameters of chronic insomnia sufferers and there is no clear evidence that improved sleep leads to meaningful changes in daytime well-being or performance.
PubMedCharacteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I.
781 Citations1999Sonia Ancoli‐Israel, Thomas Roth
The National Sleep Foundation in conjunction with the Gallup Organization conducted telephone interviews with a sample of Americans to examine the prevalence and nature of difficulty with sleep.
Sleep Medicine ReviewsUse of sleep hygiene in the treatment of insomnia
734 Citations2003Edward Stepanski, James K. Wyatt
A review of SH, how this concept has been applied and often modified over the past 24 years, and how it relates to the modern sleep disorder nosology, particularly Inadequate Sleep Hygiene is presented.
American Journal of PsychiatryPrevalence, burden, and treatment of insomnia in primary care
694 Citations1997Gregory E. Simon, Michael VonKorff
While insomnia was associated with depressive disorder and chronic medical illness, adjustment for these factors only partially accounted for the association of insomnia with disability and with health care utilization.
SLEEPSustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic Insomnia
621 Citations2003Andrew D. Krystal, James K. Walsh +5 more
Throughout 6 months, eszopiclone improved all of the components of insomnia as defined by DSM-IV, including patient ratings of daytime function, which is compelling evidence that long-term pharmacologic treatment of insomnia is efficacious.
PubMedMeta-analysis of benzodiazepine use in the treatment of insomnia.
613 Citations2000Anne Holbrook, R Crowther +3 more
The use of benzodiazepines in the treatment of insomnia is associated with an increase in sleep duration, but this is countered by a number of adverse effects and additional studies evaluating the efficacy of nonpharmacological interventions would be valuable.
Archives of Internal MedicineCognitive Behavior Therapy and Pharmacotherapy for Insomnia
581 Citations2004Gregg D. Jacobs, Edward F. Pace‐Schott +2 more
It is suggested that young and middle-age patients with sleep-onset insomnia can derive significantly greater benefit from CBT than pharmacotherapy and that CBT should be considered a first-line intervention for chronic insomnia.
PEDIATRICSSleep and Behavior Problems in School-Aged Children
554 Citations2001Mark A. Stein, Janis Mendelsohn +3 more
Parental perception of global sleep problems was surprisingly common in school-aged children receiving routine pediatric care and may be a red flag for specific sleep problems and psychiatric, social, or medical problems.
Journal of Internal MedicineSleep complaints predict coronary artery disease mortality in males: a 12‐year follow‐up study of a middle‐aged Swedish population
499 Citations2002Lena Mallon, Jan‐Erik Broman +1 more
It is shown that sleep complaints predict coronary artery disease mortality in males in a middle‐aged Swedish population over a 12-year follow-up study.
New England Journal of MedicineCurrent Status of Benzodiazepines
452 Citations1983Jan Koch‐Weser, David J. Greenblatt +2 more
JAMABenzodiazepines and Zolpidem for Chronic Insomnia
451 Citations1997Peter D. Nowell
Benzodiazepines and zolpidem produced reliable improvements in commonly measured parameters of sleep in patients with chronic insomnia, and presented challenges for developing evidence-based guidelines for the use of hypnotics in the management of chronic insomnia.
PubMedThe relationship between insomnia and health-related quality of life in patients with chronic illness.
431 Citations2002David A. Katz, Colleen A. McHorney
Insomnia is independently associated with worsened HRQOL to almost the same extent as chronic conditions such as congestive heart failure and clinical depression.
Neurobiology of AgingSleep fragmentation in the elderly: Relationship to daytime sleep tendency
379 Citations1982Mary A. Carskadon, Edward Brown +1 more
It is suggested that fragmented nocturnal sleep is a significant cause of reduced daytime well-being in elderly individuals and the continuity of both sleep and wakefulness appears to be disrupted with age.
SLEEPNREM Sleep EEG Frequency Spectral Correlates of Sleep Complaints in Primary Insomnia Subtypes
352 Citations2002Andrew D. Krystal, Jack D. Edinger +2 more
NREM EEG frequency spectral indexes appear to be physiologic correlates of sleep complaints in patients with subjective insomnia and may reflect heightened arousal during sleep.
Journal of the American Geriatrics SocietySleep Problems as a Risk Factor for Falls in a Sample of Community‐Dwelling Adults Aged 64–99 years
351 Citations2000Glenn S. Brassington, Abby C. King +1 more
If reported nighttime sleep problems and daytime sleepiness were associated with reported falling during the previous 12 months in a representatively sampled older adult population is determined.
Sleep Medicine ReviewsBeta EEG activity and insomnia
344 Citations2001Michael L. Perlis, Helli Merica +2 more
The seven studies which find that beta EEG is elevated at around sleep onset and during polysomnographic sleep in patients with insomnia are critically reviewed, two theoretical perspectives on beta EEG are presented, and the concept of hyperarousal as a three component process is discussed.
Drugs & AgingTrazodone
328 Citations1994Malini Haria, Andrew Fitton +1 more
Results from a small number of short term comparative studies in a total of 320 evaluable elderly patients with major depression, suggest that trazodone at therapeutic doses is superior to placebo and as effective as amitriptyline, imipramine, fluoxetine and mianserin in relieving depressive symptoms.
Sleep Medicine ReviewsLong sleep and mortality: rationale for sleep restriction
321 Citations2004Shawn D. Youngstedt, Daniel F. Kripke
There is sufficient evidence to warrant future testing of the hypothesis that mild sleep restriction would decrease mortality in long sleepers, and sleep restriction may be most beneficial for older adults, who tend to spend excessive time in bed and have more sleep fragmentation compared with young adults.
SLEEPA Primary Care “Friendly” Cognitive Behavioral Insomnia Therapy
320 Citations2003Jack D. Edinger, William S. Sampson
ACBT is effective for reducing subjective sleep disturbance and insomnia symptoms in primary care patients and a sizeable proportion of these patients receiving this treatment achieved clinically significant improvements by their study endpoints.
Postgraduate MedicineInsomnia and its treatment
293 Citations1984Robert Malcolm, John A. Gross
Symptomatic treatment of transient insomnias is advisable, for without treatment these sleep disorders may become persistent and the drugs of choice are the benzodiazepine hypnotics, which have minimal side effects when used for short periods in properly selected patients.
Clinical Journal of PainMajor Depression and Insomnia in Chronic Pain
272 Citations2002Keith G. Wilson, Mariane Y. Eriksson +3 more
It is suggested that patients with chronic pain and concurrent major depression and insomnia report the highest levels of pain-related impairment, but insomnia in the absence of major depression is also associated with increased pain and distress.
Journal of the American Geriatrics SocietyZolpidem Use and Hip Fractures in Older People
267 Citations2001Philip S. Wang, Rhonda L. Bohn +3 more
Although benzodiazepines have been shown to increase fall and fracture risk, zolpidem, a nonbenzodiazepine hypnotic, has been advocated as a safer alternative.
SLEEPThe Effect of Sleep Fragmentation on Daytime Function
260 Citations2002Edward Stepanski
It is clear from this literature that fragmented sleep is less restorative than consolidated sleep, and leads to sleepiness-related daytime impairment, and more studies are needed that evaluate "sub-cortical" arousals, EEG arousals and daytime function simultaneously.
Pain Research and ManagementDisrupted Sleep Patterns and Daily Functioning in Patients with Chronic Pain
250 Citations2002Lance M. McCracken, Grant L. Iverson
The view that sleep disturbance may have a bidirectional relation with other features of chronic pain is reinforced, and repairing disrupted sleep leads to an improvement in patients' daily activity and a reduction in their suffering.
Clinical TherapeuticsZaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia
246 Citations2000Kristin Weitzel, Julie M. Wickman +2 more
If pharmacologic treatment is indicated for insomnia, the choice of an agent should be guided by individual patient characteristics, and zaleplon has been shown to improve sleep variables in comparison with placebo.
Cerebrovascular DiseasesInsomnia in Ischemic Stroke Patients
244 Citations2002Antero Leppävuori, Tarja Pohjasvaara +3 more
Insomnia should be taken into consideration in treating and rehabilitating stroke patients, as it was a consequence of the stroke.
Journal of Consulting and Clinical PsychologyCognitive-Behavioral Therapy for Insomnia: Comparison of Individual Therapy, Group Therapy, and Telephone Consultations.
243 Citations2004Célyne Bastien, Charles M. Morin +3 more
CBT was effective in improving sleep parameters with all 3 methods of treatment implementation, and there was no significant difference across methods of implementation.
SLEEPPrevalence and Treatment of Insomnia in the Community: Results from the Upper Bavarian Field Study
236 Citations1991Siegfried Weyerer, Horst Dilling
Moderate/severe insomnia was strongly related to psychiatric diagnoses, the use of psychiatric in- and outpatient services and general hospitals, whereby the average annual consultation rate among mild and moderate/severe insomniacs was significantly higher compared to that for those without sleep disorders.
Human Psychopharmacology Clinical and ExperimentalSubjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia
234 Citations1998James K. Walsh, Milton K. Erman +8 more
Both trazodone and zolpidem improved self‐reported sleep latency and duration of non‐depressed, primary insomniacs; zolPidem was somewhat more efficacious at the doses studied.
American Journal of PsychiatryTrazodone for antidepressant-associated insomnia
230 Citations1994Andrew A. Nierenberg, Lenard A. Adler +3 more
Trazodone is an effective hypnotic for patients with antidepressant-associated insomnia and showed a trend toward improvement in sleep with trazodone according to a priori criteria, whereas only 13% experienced improvement with placebo.
The Journal of Clinical PsychiatrySleep Disturbances and Suicidal Behavior in Patients With Major Depression
227 Citations1997Mehmed YoEargon, Hayrettin Kara +1 more
It is demonstrated that both insomnia and hypersomnia are associated with suicidal behavior in patients with major depression.
PubMedA multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
223 Citations1994Martin B. Scharf, Thomas Röth +2 more
10 mg of zolpidem was found to be safe and effective for the long-term treatment of chronic insomnia, demonstrating hypnotic efficacy without affecting sleep stages or producing tolerance effects, rebound effects, or detrimental effects on psychomotor performance.
Journal of Clinical PsychopharmacologyTolerance to Daytime Sedative Effects of H1 Antihistamines
218 Citations2002Gary S. Richardson, Timothy Roehrs +3 more
These data provide the first objective confirmation that tolerance develops to the sedative effect of a prototypical first-generation H1 antihistamine, diphenhydramine, on this dosing regimen.
PubMedInsomnia in primary care patients.
215 Citations1999Tamar Shochat, Jason L. Umphress +2 more
As expected, patients with chronic insomnia had the most severe sleep complaints as well as the poorest daytime functioning, and exhibited the most help-seeking behaviors.
The Journal of Clinical PsychiatrySleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic
188 Citations1999R Élie, Eckart Rüther +3 more
Zaleplon appears to provide a favorable safety profile, as indicated by the absence of rebound insomnia and withdrawal symptoms once treatment was discontinued, and was effective in the treatment of insomnia in outpatients with DSM-III-R insomnia.
SLEEPPhysician Education in Sleep and Sleep Disorders: A National Survey of U.S. Medical Schools
185 Citations1993Raymond C. Rosen, Mark R. Rosekind +3 more
Overall, it appears that physician education in sleep and sleep disorders is largely inadequate, despite increasing evidence of the role of sleep in patient health and well-being.
Journal of Clinical PsychopharmacologyResidual Effects of Middle-of-the-Night Administration of Zaleplon and Zolpidem on Driving Ability, Memory Functions, and Psychomotor Performance
180 Citations2002Joris C. Verster, Edmund R. Volkerts +9 more
Zaleplon (10 and 20 mg) is a safe hypnotic devoid of next-morning residual impairment when used in the middle of the night and significantly impaired performance on all psychomotor and memory tests.
The Journal of Clinical PsychiatryZolpidem for Persistent Insomnia in SSRI-Treated Depressed Patients
174 Citations1999Gregory M. Asnis, Amil Chakraburtty +7 more
In this defined patient population, zolpidem, 10 mg, was effectively and safely co-administered with an SSRI, resulting in improved self-rated sleep, daytime functioning, and well-being.
Sleep Medicine ReviewsMeasuring outcomes in randomized clinical trials of insomnia treatments
169 Citations2003Charles M. Morin
The need to evaluate outcome from multiple perspectives and to develop a core-assessment battery that would consider efficacy, clinical significance, and cost-effectiveness are discussed.
Clinical Pharmacology & TherapeuticsSleep in patients with Parkinson's disease and normal subiects prior to and following levodopa administration
168 Citations1971Anthony Kales, R. Ansel +3 more
Values for sleep induction and sleep maintenance were essentially unaltered by the administration of levodopa, and the clinical implications in terms of evaluating and treating the moderately severe insomnia in parkinsonian patients are described.
PubMedPsychotropic medication and priapism: a comprehensive review.
165 Citations1990James Westfall Thompson, M R Ware +1 more
It is essential that patients who are to receive psychotropic medications be forewarned about priapism, and patients should be questioned concerning prior occurrence of prolonged erections, since a past history of delayed detumescence is present in approximately 50% of subsequent cases of priapsism.
SLEEPEight Weeks of Non-Nightly Use of Zolpidem for Primary Insomnia
157 Citations2000James K. Walsh, Thomas Röth +6 more
Zolpidem was found to be effective in initiating and maintaining sleep on nights taken, as compared to placebo, based upon the Patient's Global Ratings and all subjective sleep variables, and no evidence of rebound insomnia was found on nights that zolPidem was not taken.
SLEEPSleep Onset Insomnia, Sleep Maintaining Insomnia and Insomnia With Early Morning Awakening—Temporal Stability of Subtypes in a Longitudinal Study on General Practice Attenders
154 Citations1994Fritz Hohagen, Christoph Käppler +4 more
The findings of the present study illustrate that cross-sectional studies focusing on subtypes of insomnia, e.g. sleep-onset insomnia, may lead to erroneous results.
American Journal of PsychiatryEfficacy of behavioral versus triazolam treatment in persistent sleep- onset insomnia
152 Citations1991H Y McClusky, J B Milby +3 more
Comparisons showed that triazolam group latencies returned toward baseline, while behavioral group gains were maintained at follow-up, and one treatment strategy implied by these results would be to combine these two interventions concurrently.
Behaviour Research and TherapyA controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia
152 Citations1989Colin A. Espie, William R. Lindsay +3 more
Only active treatments were associated with significant improvement, but the nature of treatment gains varied, in particular, stimulus control improved sleep pattern, whereas relaxation affected perception of sleep quality.
Journal of Allergy and Clinical ImmunologySedative effects of antihistamines
149 Citations1987Thomas Roth, Timothy Roehrs +3 more
It is demonstrated that loratadine (10 and 40 mg doses) did not have clinically significant central nervous system activity, whereas diphenhydramine increases sleepiness and disrupts performance efficiency.
British Journal of Clinical PharmacologyTrazodone enhances sleep in subjective quality but not in objective duration.
146 Citations1983Iain Montgomery, Isabelle P. Oswald +2 more
Trazodone halved the frequency of arousals interrupting sleep, and it reduced the time spent in stage 1 (drowsiness), and it increased the duration of slow-wave sleep, with a negative rebound following withdrawal.
Archives of General PsychiatryAbnormal Electroencephalographic Sleep Profiles in Major Depression
140 Citations1996Michael E. Thase
Depressed patients characterized by higher severity and/or an abnormal electroencephalographic sleep profile were relatively less responsive to cognitive behavior therapy.
GerontologySleep Patterns and Mortality among Elderly Patients in a Geriatric Hospital
138 Citations2000K. Manabe, Toshifumi Matsui +5 more
The presence of nighttime insomnia and sleep-onset delay remained associated with a higher risk of mortality, and may be one of the symptoms indicating poor health or functional deficits, and be an independent risk factor for survival.
Progress in Neuro-Psychopharmacology and Biological PsychiatryInsomnia in depression: Differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone
132 Citations2002G. Saletu‐Zyhlarz, Manal Hassan Abu‐Bakr +7 more
It is demonstrated that depression induced significant changes in objective and subjective sleep and awakening quality, which were counteracted by 100 mg of trazodone, thus suggesting a key-lock principle in the treatment of depression.
American Journal of PsychiatryDiagnostic concordance for DSM-IV sleep disorders: a report from the APA/NIMH DSM-IV field trial
132 Citations1994Daniel J. Buysse, C F Reynolds +8 more
Site-related variability indicates a need for greater standardization in the application of sleep disorder diagnostic criteria, and the distribution of diagnoses highlights the importance of psychiatric and behavioral factors in the assessment of insomnia.
The Journal of Clinical PharmacologyDiphenhydramine in Insomniac Family Practice Patients: A Double‐Blind Study
124 Citations1983Karl Rickels, Richard J. Morris +4 more
Results obtained indicate that diphenhydramine improved various sleep parameters, including sleep latency, to a significantly higher degree than did placebo, and supports the use of 50 mg diphenHydramine as an OTC sleep aid in the treatment of temporary mild to moderate insomnia.
Journal of GerontologySleep in Older Persons: Sleep Structures of 50- to 60-year-old Men and Women
118 Citations1982Wilse B. Webb
There was an increase in the reliability of measures in the older persons across nights and when a modified scoring procedure for slow wave sleep based on frequency alone was used, the typically reported age decline was not found.
Behavior TherapyPsychological management of insomnia: A clinical replication series with 100 patients
114 Citations1994Charles M. Morin, Jackie Stone +2 more
Results from daily sleep diaries showed that patients were sleeping more efficiently after treatment, as evidenced by significant reductions of sleep onset latency, wake after sleep onset, and early morning awakening.
PubMedConsequences of insomnia and its therapies.
109 Citations2001Ruth M. Benca
Patients with chronic insomnia have higher rates of psychiatric and medical illnesses, and insomnia is an important risk factor in the development of depression.
CNS DrugsClinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon
108 Citations2003Leah M. Hesse, Lisa L. von Moltke +1 more
Few clinically important interactions appear to have been reported in the literature with zaleplon, zolpidem and zopiclone, and the fact that these drugs are newer to the market and have not been as extensively studied as the conventional benzodiazepines may be the reason for this.
Journal of Internal MedicineInsomnia, metabolic rate and sleep restoration
101 Citations2003Michael H. Bonnet, Donna L. Arand
Bonnet MH, Arand DL (Wright State University, Kettering Medical Center, and Wallace Kettering Neuroscience Institute, Dayton, OH, USA).
PsychopharmacologyAcute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans
99 Citations1999Craig R. Rush, Robert W. Baker +1 more
Examination of the acute behavioral effects and abuse potential of three drugs commonly used to treat sleep disorders, trazodone, zolpidem and triazolam, and placebo in ten male volunteers with histories of alcohol and drug abuse suggests that traZodone has less abuse potential than triazolate, and may be a viable alternative to benzodiazepine hypnotics in individuals with historiesof alcohol or drug abuse.
Journal of Clinical PsychopharmacologyComparative Hypnotic Effects of Flurazepam, Triazolam, and Placebo
98 Citations1984Merrill M. Mitler, Wesley F. Seidel +3 more
Daytime testing revealed significantly decreased daytime alertness and decreased performance for flurazepam subjects during weeks 3 to 7, although these effects reverted toward baseline despite continued drug administration, suggesting that the onset of the rebound insomnia depended on the rate of drug washout.
SLEEPCan We Mix Behavioral Therapy With Hypnotics When Treating Insomniacs?
96 Citations1997Peter Hauri
It is concluded that when teaching sleep hygiene and behavioral therapy to insomniacs, it might be advantageous to disallow the concomitant use of hypnotics as needed.
PubMedEffects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis.
96 Citations1996James K. Walsh, Mark J. Muehlbach +3 more
Short term hypnotic therapy improves sleep in patients with RA and appears to improve morning stiffness and daytime sleepiness.
PubMedSleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients.
96 Citations1990Martin B. Scharf, Barry A. Sachais
Trazodone (150 mg to 400 mg) was administered to six depressed patients with significant sleep disturbances in an 8-week single-blind study design and patients showed a significant improvement in symptoms of depression and in their polysomnographic-determined sleep architecture.
International Journal of Geriatric PsychiatryZaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia
93 Citations2000Jan Hedner, Roger Yaeche +3 more
Zaleplon is an effective and safe hypnotic for the treatment of insomnia in the elderly and its pharmacology and pharmacokinetics suggest a safety profile that is improved over other hypnotics.
International Clinical PsychopharmacologyZaleplon improves sleep without producing rebound effects in outpatients with insomnia
92 Citations2000June M. Fry, Martin B. Scharf +2 more
Results show that zaleplon provides effective treatment of insomnia with a favourable safety profile and a significantly greater incidence of withdrawal symptoms and a suggestion of sleep difficulty after treatment discontinuation was seen with zolpidem compared to placebo.
Sleep And BreathingKnowledge and Attitudes of Primary Care Physicians Toward Sleep and Sleep Disorders
90 Citations2002Klara K. Papp, Carolyn E. Penrod +1 more
Though virtually all agreed that prevention counseling should be a part of patient care, fewer agreed that they spend more time counseling patients on the benefits of sleep than of diet or exercise.
Journal of Clinical PsychopharmacologyDiphenhydramine Alters the Disposition of Venlafaxine Through Inhibition of CYP2D6 Activity in Humans
89 Citations2001Étienne Lessard, Marie‐Andrée Yessine +6 more
Diphenhydramine, at therapeutic doses, inhibits CYP2D6-mediated metabolism of venlafaxine in humans, and Clinically significant interactions could be encountered during the concomitant administration of diphenHydramine and other antidepressant or antipsychotic drugs that are substrates of CYP 2D6.
Clinical Pharmacology & TherapeuticsRebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines
88 Citations1991Anthony Kales, Rocco L Manfredi +4 more
It is indicated that even under conditions of brief, intermittent use and withdrawal, triazolam and, to a lesser degree, temazepam produce rebound insomnia after abrupt withdrawal, thereby predisposing to drug‐taking behavior and increasing the potential for drug dependence.
PubMedSleep loss: a preventable cause of mania and other excited states.
88 Citations1989Thomas A. Wehr
Attention to the possible role of sleep loss and light as triggering factors in the pathogenesis of mania may help clinicians and patients to identify some of the factors that influence the natural course of the bipolar illness and to devise strategies for its prevention and treatment.
PsychopharmacologyClinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia
79 Citations1994Liborio Parrino, Maria Cristin Spaggiari +3 more
The course of polysomnographic modifications was consistently associated with significant improvement of VAS and HAM-D scores during the active treatment period and by poor scores of the baseline and withdrawal periods, suggesting an effective slow acting serotonin-related drug with both sedative and antidepressant properties may open new perspectives in the treatment of chronic insomnia.
Clinical NeuropharmacologyMinimal Rebound Insomnia After Treatment with 10-mg Zolpidem
77 Citations1997J. Catesby Ware, James K. Walsh +4 more
There was no significant correlation between rebound insomnia and the level of initial insomnia, the degree of response to treatment in week 4, or the amount of tolerance that developed during drug use.
Journal of International Medical ResearchA Double-Blind, Comparative Study of Zolpidem and Placebo in the Treatment of Insomnia in Elderly Psychiatric In-Patients
75 Citations1992Stevan Shaw, H Curson +1 more
It is concluded that, in elderly psychiatric patients, 10 mg/day zolpidem can be used to treat insomnia and can be safely added to concomitant psychotropic treatment without inducing daytime drowsiness.
PubMedSleep in late-life recurrent depression. Changes during early continuation therapy with nortriptyline.
72 Citations1991Charles F. Reynolds, Carolyn C. Hoch +8 more
The sleep of thirty elderly patients with recurrent unipolar depression was examined and the single best correlate of clinical change was prolongation of REM sleep latency, consistent with the concept that anti-depressant drug efficacy may depend upon strengthening of the homeostatic regulation of sleep and upon changes in the REM-sleep regulation.
PsychopharmacologyA comparison of the effects of flurazepam 30 mg and triazolam 0.5 mg on the sleep of insomniacs
72 Citations1976Gerald W. Vogel, Katherine Barker +2 more
Both significantly reduced objective and subjective measures of insomnia, such as total wake time and sleep latency, and there were no remarkable side or toxic effects with either drug.
The Journal of Clinical PharmacologyClinical Evaluation of Diphenhydramine Hydrochloride for the Treatment of Insomnia in Psychiatric Patients: A Double‐Blind Study
68 Citations1990Yoshio Kudo, Masanao Kurihara
Diphenhydramine hydrochloride appears to be effective in the treatment of insomnia, but the appropriate dosage will depend on previous medical treatment for insomnia.
British Journal of Clinical PharmacologyHYPNOTIC EFFICACY OF TEMAZEPAM: A LONG‐TERM SLEEP LABORATORY EVALUATION
60 Citations1979Merrill M. Mitler, Mary A. Carskadon +6 more
Temazepam seemed to be both safe and effective at doses of 15 and 30 mg with up to 5 weeks of ingestion, and no evidence was found for development of tolerance or rebound effects.
PubMedCharacterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists.
51 Citations1995Witek Tj, Canestrari Da +3 more
It is confirmed that subjective and objective measures of sleepiness and psychomotor performance occur following single doses of diphenhydramine and chlorpheniramine, but not terfenadine.
PubMedClinical distinctions between long-acting and short-acting benzodiazepines.
49 Citations1992Wallace B. Mendelson
A growing body of data indicates that the short-acting hypnotics are less likely to be associated with falls and hip fractures in the elderly and also have less respiratory depressant qualities, compared with the older long-acting agents.
Journal of International Medical ResearchLong-Term Polysomnographic Study of the Efficacy and Safety of Zolpidem in Elderly Psychiatric In-Patients with Insomnia
48 Citations1993J Rummer, L Guendel +5 more
The results suggest that, contrary to other hypnotics, Zolpidem, after long-term administration, improves objective sleep parameters and may normalize a disturbed sleep architecture.
Drug Intelligence & Clinical PharmacyEvaluation of Temazepam and Diphenhydramine as Hypnotics in a Nursing-Home Population
47 Citations1987Ronald B. Stewart, John R. Meuleman +2 more
Several instances of daytime hypersomnolence were noted in subjects taking temazepam and DPH, but none in subjects given placebo, and no significant difference in tests of neurologic function was noted.
The Journal of Clinical PharmacologyEstazolam and Flurazepam: A Multicenter, Placebo‐Controlled Comparative Study in Outpatients with Insomnia
45 Citations1990Martin B. Scharf, Paul B Roth +2 more
Estazolam and flurazepam effectively, and comparably, relieved insomnia when administered for 7 nights in adult patients complaining of insomnia.
Evaluation & the Health ProfessionsSatisfaction and Well-Being of Primary Care Providers in Managed Care
44 Citations2002Donald K. Freeborn, Roderick S. Hooker +1 more
PsychopharmacologyThe drug treatment of depression in general practice: a comparison of nocte administration of trazodone with mianserin, dothiepin and amitriptyline
40 Citations1988Rebecca Blacker, N J Shanks +2 more
Trazodone and dothiepin were of greatest benefit and mianserin was of least benefit in this respect, and all four treatments were associated with improvements in sleep quality and ease of getting to sleep.
Journal of Clinical PsychopharmacologySleep Evaluation in Chronic Insomniacs during 14-Day Use
40 Citations1990Daniel F. Kripke, Peter Hauri +2 more
The sleep of patients taking flurazepam 30 mg did not differ significantly from the sleep of those receiving the 15 mg dose for any of the five major sleep variables at any interval, and Objective EEG and subjective PSQ sleep variables showed significant positive correlations.
The Journal of Clinical PharmacologyEfficacy Without Tolerance or Rebound Insomnia for Midazolam and Temazepam After Use for One to Three Months
38 Citations1987Richard P. Allen, Joseph Mendels +3 more
The results of this study suggest that patients with chronic insomnia may benefit from 30 to 90 days of treatment, and a three‐factor model that separates pharmacologic from behavioral and psychologic effects of hypnotics was proposed to explain these results.
European PsychiatryThe effects of trazodone on sleep disturbances induced by brofaromine
36 Citations1999P.M.J. Haffmans, M.S. Vos
A low dose of trazodone may be a safe and effective agent in the treatment of MAO-I induced insomnia.
PubMedRapid resolution of first episodes of mania: sleep related?
36 Citations1994Nancy Nowlin-Finch, Lori L. Altshuler +2 more
The possibility is raised that sleep restoration might induce a rapid antimanic response in patients experiencing their first episode of mania.
American Journal of Physiology-Regulatory, Integrative and Comparative PhysiologyAttenuation of sleep propensity, core hypothermia, and peripheral heat loss after temazepam tolerance
32 Citations2000Saul S. Gilbert, Helen J. Burgess +2 more
Results indicate that the thermoregulatory system may be functionally involved in the regulation of sleepiness in young male subjects before and immediately after 7 consecutive days of temazepam.
International Clinical PsychopharmacologyA Double-blind Placebo-controlled Trial of Zopiclone 7·5 mg and Temazepam 20 mg in Insomnia
30 Citations1990CHIN CHEUK NGEN, Ramli Hassan
Zopiclone is an effective hypnotic comparable to temazepam in the treatment of insomnia and had significant hypnotic properties when compared to placebo.
PsychopharmacologyThe efficacy and residual effects of trazodone (150 mg nocte) and mianserin in the treatment of depressed general practice patients
27 Citations1988C. A. L. Moon, Anuradha Davey
There was strong evidence that psychomotor performance changed over the period of the trial, and the trazodone treatment group showed a smaller reduction in adverse events from baseline than was seen in the mianserin group.
PubMedDose effects of temazepam tablets on sleep.
23 Citations1986Timothy Roehrs, G Vogel +6 more
Acute and short term temazepam improved the sleep of these volunteers by reducing sleep latency and increasing sleep time compared to the placebo baseline, with 30 mg having a greater or more consistent effect than 15 mg.
…